Y-Intercept (HK)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Y-Intercept (HK)’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,355	Closed	-$320K	–	2049
2024 Q1	$320K	Buy	+20,355	New	+$313K	0.02%	929
2022 Q3	–	Sell	-18,651	Closed	-$245K	–	1348
2022 Q2	$245K	Buy	+18,651	New	+$206K	0.03%	639

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Y-Intercept (HK)'s DCPH Position: Q2 2024 in Review

Y-Intercept (HK) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 20,355 shares — an estimated $320K sold.

Y-Intercept (HK) first reported a position in DCPH in Q2 2022 and held it in 2 quarters. The position peaked at $320K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Y-Intercept (HK) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Y-Intercept (HK) sold 20,355 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $320K.
Y-Intercept (HK) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $320K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.